Oriental College of Pharmacy Admission 2026

Navi Mumbai, Maharashtra Approved By: AICTENAAC Private Estd: 2004 Gender: Coed
Angel Youth Education TeamContent writer
Updated At : Nov 18, 2026 02:04 PM

OCP Navi Mumbai admissions for the 2026-27 session are anchored by MHT CET (PCB group) for B.Pharm and GPAT for M.Pharm, both through the DTE Maharashtra CAP. The key dates for the current cycle are listed below.

EventDateStatus
MHT CET RegistrationJanuary 10 to February 24, 2026Concluded
MHT CET Exam (PCB Group)April 21 to 26, 2026Concluded
MHT CET ResultJune 16, 2026Declared
B.Pharm CAP Registration (DTE Maharashtra)July to September 2026 (Tentative)In progress
GPAT 2026 (for M.Pharm)March 7, 2026Concluded
GPAT 2026 ResultApril 7, 2026Declared
M.Pharm CAP Counselling (DTE Maharashtra)August to September 2026 (Tentative)In progress

The table below shows the entrance exams accepted for each programme at OCP Navi Mumbai for the 2026-27 session.

ProgrammeExam AcceptedRoute
B.Pharm (100 seats)MHT CET (PCB Group) / NEET (All India seats)DTE Maharashtra CAP
B.Pharm Lateral EntryMHT CET (MHTR Group)DTE Maharashtra lateral entry CAP
M.Pharm (45 seats, 3 specialisations)GPATDTE Maharashtra M.Pharm CAP

OCP Navi Mumbai follows the DTE Maharashtra centralised counselling process for both B.Pharm and M.Pharm. Being a private aided institution with no management quota, all seats are merit-based through the CAP.

B.Pharm Admission

Eligibility for B.Pharm requires 10+2 with Physics, Chemistry, and Biology or Mathematics from a recognised board, with a minimum aggregate of 50% in the PCB or PCM group. A non-zero MHT CET (PCB group) score is mandatory for Maharashtra state quota seats. All India candidates may use NEET scores for designated seats.

The selection stages are:

  • Appear for MHT CET (PCB group) or NEET
  • Register on the DTE Maharashtra CAP portal at cetcell.mahacet.org
  • Fill college preferences and receive merit-based seat allotment
  • Report to OCP Navi Mumbai for document verification and fee payment to confirm the seat

MHT CET closing percentile for OCP Navi Mumbai B.Pharm under General category has typically ranged in the 60 to 80 percentile band for state merit seats in recent CAP rounds, though this varies each year.

B.Pharm Lateral Entry

D.Pharm holders from a PCI-recognised institution may seek direct admission to the second year of B.Pharm through the DTE Maharashtra lateral entry CAP. Minimum eligibility is D.Pharm with 50% aggregate. This route bypasses the first year of B.Pharm and has a correspondingly lower total fee.

M.Pharm Admission

M.Pharm eligibility requires a B.Pharm degree with a minimum of 55% aggregate (50% for reserved category candidates). A non-zero positive GPAT score, conducted by NTA, is mandatory. Admission is through the DTE Maharashtra M.Pharm CAP process. OCP Navi Mumbai offers M.Pharm in Pharmaceutics, Pharmacology, and Quality Assurance, with 15 seats in each specialisation.

Scholarships

Students admitted to OCP Navi Mumbai are eligible for Maharashtra state government scholarship schemes based on category, family income, and merit seat status.

ScholarshipEligibilityCoverage
Rajshree Chhatrapati Shivaji Maharaj EBC YojanaOpen-category students with family income below EBC threshold, admitted on merit seatsTuition fee waiver
OBC ScholarshipOther Backward Class students admitted through CAPState-determined scholarship amount
J and K Migration ScholarshipStudents who are migrants from Jammu and KashmirState-determined scholarship amount

Students must apply for these scholarships through the Maharashtra state scholarship portal (mahascholar.gov.in) within the prescribed deadline each academic year. The deadline for scholarship application is typically the first semester of admission.

Confused about admission in Oriental College of Pharmacy Navi Mumbai?Talk to our expert counsellors – it's free.
Chat with us

Get In Touch With Us

By submitting this form you agree that Angel Youth Education may use the details you provide to respond to you, as described in our privacy notice.